To further investigate the pharmacological effect of AZG in this murine GBM model, IHC staining for the tumor proliferation marker KI67 was performed, revealing a marked decrease in cell proliferation in the AZG-treated mice (Figures 7E-F). Here, MKI67 is linked to glioblastoma.